Cannabis stocks lag in 2026 as hopes of an imminent resheduling of marijuana under the Controlled Substances Act fade. Read more here.

Rescheduling cannabis to a Schedule 3 drug, if it happens, represents a long-term industry tailwind.

Institutions bought this cannabis stock ahead of rescheduling progress, but did they sell on the news?

The global cannabis market is rapidly evolving, with President Trump’s decision to federally reschedule marijuana in the ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug. Publicly traded ...

While the AI trade was faltering and the broader market was facing increasing selling pressure on Friday, cannabis stocks were performing quite well. Reports that President Donald Trump plans to ...

Aurora Cannabis Inc. reported in line financial results for Q3-2026 with increasing revenue and free cash flow. Learn more about ACB stock here.

The cannabis sector is one which many may have rightly described as a bubble seven or eight years ago. That’s because it was. Valuations in this sector got to obscene levels, with plenty of top ...

Roth Capital Markets analyst Bill Kirk reiterated a “Neutral” rating on ACB and lowered his 12-month price target to C$5.00 ...

LAS VEGAS (KLAS) — Nevada’s illegal cannabis market remains resilient as dispensaries lower costs to appeal to customers on ...